Hematologic Tumors
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Rutgers University Study of the Genetics of Blood Cancers (NCT07714044) | Rutgers, The State University of New Jersey | 2026-08-01 |
| Pharmacokinetic (PK) Study of Homoharringtonine (Omacetaxine Mepesuccinate) Administered Subcutaneously to Patients With Advanced Solid and Hematologic Tumors (NCT00675350) | ChemGenex Pharmaceuticals | 2008-04-01 |
Track Hematologic Tumors automatically
Every clearance here is in the API, with alerts when new ones post.